SCHEMBL6359635

SCHEMBL6359635

CC(C)(C)OC(=O)N[C@H](C(=O)O)[C@H]1CC[C@@H](O)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 3/20 0.44
CTSS P25774 4/20 0.40
CTSK P43235 4/20 0.40
KMT2A Q03164 2/20 0.39
MMP13 P45452 2/20 0.39
MMP2 P08253 1/20 0.39
MMP3 P08254 1/20 0.39
CHRM2 P08172 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRM3 P20309 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
BTK Q06187 1/20 0.37
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
CTSL P07711 1/20 0.36
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6360209 1.00 AAK1 (0.44) AAK1CTSSCTSKKMT2AMMP13
SCHEMBL3119969 1.00 AAK1 (0.44) AAK1CTSSCTSKKMT2AMMP13
SCHEMBL25213681 1.00 AAK1 (0.44) AAK1CTSSCTSKKMT2AMMP13
SCHEMBL6359636 1.00 AAK1 (0.44) AAK1CTSSCTSKKMT2AMMP13
SCHEMBL1273387 0.94 AAK1 (0.48) AAK1CTSSCTSKKMT2ACA1
SCHEMBL1349095 0.94 AAK1 (0.48) AAK1CTSSCTSKKMT2ACA1
SCHEMBL1349093 0.94 AAK1 (0.48) AAK1CTSSCTSKKMT2ACA1
SCHEMBL12910419 0.88 AAK1 (0.44) AAK1CTSSCTSKKMT2AMMP13
SCHEMBL20588780 0.88 AAK1 (0.44) AAK1CTSSCTSKKMT2AMMP13
SCHEMBL15009165 0.88 AAK1 (0.44) AAK1CTSSCTSKKMT2AMMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2240506-B1 INHIBITORS OF IAP GENENTECH INC (US) 2012-12-26 EP disclosed
US-20090176822-A1 PYRROLIDINE INHIBITORS OF IAP GENENTECH, INC. (US) 2009-07-09 US disclosed
WO-2005100334-A1 DIPEPTIDYL PEPTIDASE-IV INHIBITORS PFIZER PRODUCTS INC. (US) 2005-10-27 WO disclosed
US-20050234065-A1 Dipeptidyl peptidase-IV inhibitors PFIZER INC 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234065-A1 Dipeptidyl peptidase-IV inhibitors ALPI, DPP4, SI AAK1 778/4885CTSS 823/4885CTSK 2191/4885
US-20090176822-A1 PYRROLIDINE INHIBITORS OF IAP BIRC5, XIAP, BIRC2 AAK1 1999/4885CTSS 1651/4885CTSK 1703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.